We are live on ! Find out more
CELG.RT

Bristol-Myers Squibb Rights
CELG.RT

17 hedge funds and large institutions have $92.4K invested in Bristol-Myers Squibb Rights in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

6% more funds holding

Funds holding: 16 → 17 (+1)

0% less ownership

Funds ownership: 0.02% → 0.02% (-0%)

41% less capital invested

Capital invested by funds: $157K → $92.4K (-$64.2K)

Holders
17
Holders Change
+1
Holders Change %
+6.25%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$2.28K
2
Citadel Advisors
Citadel Advisors
Florida
+$691
3
UBS Group
UBS Group
Switzerland
+$85
4
CCP
Carmel Capital Partners
California
+$80
5
WP
WealthPLAN Partners
Nebraska
+$2

Top Sellers

Rank Fund Capital Flow
1
FCM
FourWorld Capital Management
New York
-$69K
Name Holding Trade Value Shares
Change 		Change in
Stake
MS
1
Maven Securities
Jersey
$46.8K – – –
TCA
2
Transcend Capital Advisors
New Jersey
$14.1K – – –
DC
3
Davenport & Co
Virginia
$11.8K – – –
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$8.48K +$2.28K +17,150 +34%
Citadel Advisors
5
Citadel Advisors
Florida
$5.33K +$691 +5,192 +14%
Fifth Third Bancorp
6
Fifth Third Bancorp
Ohio
$2.4K – – –
PAG
7
Private Advisor Group
New Jersey
$1.8K – – –
TPA
8
Trivium Point Advisory
Connecticut
$1.2K – – –
Bank of America
9
Bank of America
North Carolina
$200 – – –
UBS Group
10
UBS Group
Switzerland
$77 +$85 +640 New
CCP
11
Carmel Capital Partners
California
$72 +$80 +600 New
Northwestern Mutual Wealth Management
12
Northwestern Mutual Wealth Management
Wisconsin
$29 – – –
Morgan Stanley
13
Morgan Stanley
New York
$20 – – –
OC
14
Oakworth Capital
Alabama
$15 – – –
Wells Fargo
15
Wells Fargo
California
$3 – -1 -4%
WP
16
WealthPLAN Partners
Nebraska
$1 +$2 +12 New
FCM
17
FourWorld Capital Management
New York
– -$69K -100,000 Closed

CELG.RT Hedge Fund Activity: Q1 2023 in Review

17 of the 6,277 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb Rights (CELG.RT) for Q1 2023, worth a combined $92.4K — down 41% from $157K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new CELG.RT positions and 2 closed out — a net gain of 1 holder — while 2 added to existing stakes and 1 trimmed.

The largest buyer was Susquehanna International Group, adding an estimated $2.28K. The largest seller was FourWorld Capital Management, exiting entirely with an estimated $69K sold.

  • 17 institutional investors held Bristol-Myers Squibb Rights (CELG.RT) as of Q1 2023, up from 16 in Q4 2022.
  • Funds reported $92.4K of Bristol-Myers Squibb Rights stock for Q1 2023, down 41% quarter-over-quarter.
  • 3 funds opened new Bristol-Myers Squibb Rights positions in Q1 2023 and 2 closed out, a net change of +1 holder.
  • The largest Bristol-Myers Squibb Rights buyer in Q1 2023 was Susquehanna International Group, an estimated $2.28K added.
  • The largest Bristol-Myers Squibb Rights seller in Q1 2023 was FourWorld Capital Management, an estimated $69K sold.

Based on aggregated 13F filings for Q1 2023.